The condition of patients with blood uric acid 623 μmol/L alone is usually relatively mild and can be improved by effective uric acid-lowering therapy. If the patient is combined with gout, gouty nephropathy and other comorbidities, or the presence of hypertension, atherosclerosis and other metabolic syndromes, the condition is usually more serious.
Blood uric acid 623 μmol/L is significantly higher than the normal value, and if the patient’s fasting blood uric acid is greater than 420 μmol/L in two tests not on the same day, the patient is considered to have hyperuricemia. Some patients with hyperuricemia do not develop complications such as gouty arthritis and gout stones throughout their lives, i.e., asymptomatic hyperuricemia, which is relatively mild.
If hyperuricemia patients with blood uric acid 623 μmol/L have the above comorbidities, or there are manifestations of metabolic syndrome such as diabetes mellitus, hypertension, atherosclerosis and hyperlipidemia, which have an impact on the function of multiple organs and systems of the patient and seriously affect the treatment of their lives, the condition is usually more serious.
Patients with blood uric acid 623μmol/L are recommended to consult the rheumatology and immunology department of regular hospitals and receive standardized treatment under the guidance of doctors.